Abstract
A variety of terms, including Ca2+ antagonist, Ca2+ channel blocker, and slow channel blocker, have been applied to a structurally heterogeneous group of agents including the clinically available verapamil, nifedipine, and diltiazem (Fig. 1; for general reviews see Fleckenstein, 1977, 1983). With the recent introduction of 1,4-dihydropyridine analogues of nifedipine that function as calcium channel activators (Fig. 2, Bay K 8644 and CGP 28 392; Schramm et al, 1983), a more appropriate generic title might be calcium channel ligands.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almers, W., McCleskey, E. W., and Palade, P. T., 1984, A non-selective cation conductance in frog muscle membrane blocked by micromolar external calcium ions, J. Physiol. (Lond.) 353:565–583.
Bean, B. P., 1984, Nitrendipine block of cardiac calcium channels: High affinity binding to the inactivated state, Proc. Natl. Acad. Sci. U.S.A. 81:6388–6392.
Bellemann, P., Schade, A., and Towart, R., 1983, Dihydropyridine receptor in rat brain labelled with [H]nimodipine, Proc. Natl. Acad. Sci. U.S.A. 80:2356–2360.
Bolger, G. T., Gengo, P. T., Klockowski, R., Luchowski, E., Siegel, H., Janis, R. A., Toggle, A. M., and Triggle, D. J., 1983, Characterization of binding of the Ca2+ channel antagonist, Hilnitrendipine, to guinea pig ileal smooth muscle, J. Pharmacol. Exp. Ther. 225:291–309.
Borden, L. A., Czajkowski, C., Chan, C. Y., and Farb, D. H., 1984, Benzodiazepine receptor synthesis and degradation by neurons in culture. Science 226:857–860.
Edelhoch, H., and Osborne, J. C., Jr., 1976, The thermodynamic basis of the stability of proteins, nucleic acids and membranes. Adv. Protein Chem. 30:183–250.
Erman, R. D., Yamamura, H. I., and Roeske, W. R., 1983, The ontogeny of specific binding sites for the calcium channel antagonist, nitrendipine, in mouse heart and brain. Brain Res. 278:327–331.
Fleckenstein, A., 1977, Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle, Annu. Rev. Pharmacol. Toxicol. 17:149–166.
Fleckenstein, A., 1983, Calcium Antagonism in Heart and Smooth Muscle. Experimental Facts and Therapeutic Prospects, Wiley Interscience, New York.
Fossheim, R., Svarteng, K., Mostad, A., Romming, C., Shefter, E., and Triggle, D. J., 1982, Crystal structures and pharmacologic activities of calcium channel antagonists: 2,6-Dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl, 4-methyl, 3-nitro, 4-nitro, and 2,4-dinitrophenyl)-l,4-dihydropyridine, J. Med. Chem. 25:126–131.
Frankenhaueser, B., and Hodgkin, A. L., 1957, The action of calcium on the electrical properties of squid axons, J. Physiol. (Lond.) 137:218–244.
Galizzi, J. P., Fosset, M., and Lazdunski, M., 1984, Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle, Eur. J. Biochem. 144:211–215.
Gardner, J. M., and Fambrough, D. M., 1979, Acetylcholine receptor degradation measured by density labelling: Effects of cholinergic ligands and evidence against recycling, Cell 16:661–674.
Gilman, A. G., 1984, G Proteins and dual control of adenylate cyclase. Cell 36:577–579.
Glossman, H., Ferry, D. R., Lübbecke, F., Mewes, R., and Hofmann, F., 1982, Calcium channels: Direct identification with radioligand binding studies, Trends Pharm. Sci. 3:431–437.
Gomperts, B. D., 1983, Involvement of guanine nucleotide-binding protein in the gating of by receptors. Nature 306:64–66.
Gould, R. J., Murphy, K. M. M., and Snyder, S. H., 1982, [3H]Nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists, Proc. Natl. Acad. Sci. U.S.A. 79:3656–3660.
Halvorsen, S. W., and Nathanson, N. M., 1984, Ontogenesis of physiological responsiveness and guanine nucleotide sensitivity of cardiac muscarinic receptors during chick embryonic development. Biochemistry 23:5813–5821.
Hamilton, C. A., Dalrymple, H. W., Reid, J. L., and Summer, D. J., 1984, The recovery of a-adrenoceptor function and binding sites after phenoxybenzamine. An index of receptor turnover, Naunyn Schmiedebergs Arch. Pharmacol. 325:34–41.
Hess, P., and Tsien, R. W., 1984, Mechanism of ion permeation through calcium channels. Nature 309:453–456.
Hess, P., Lansman, J. B., and Tsien, R. W., 1984, Different modes of Ca channel gating behavior favored by dihydropyridine Ca agonists and antagonists. Nature 311:538–544.
Hille, B., 1977, Local anesthetics: Hydrophihc and hydrophobic pathways for the drugreceptor reaction, J. Gen. Physiol. 69:497–515.
Hille, B., 1984, Modifiers of Gating, in: Ionic Channels of Excitable Membranes Sinauer Associates, Sunderland, A, pp. 303–328.
Hof, R. P., Rüegg, U. T., Hof, A., and Vogel, A., 1985, Stereoselectivity at the calcium channel: Opposite action of the enantiomers of a 1, 4-dihydropyridine, J. Cardiovasc. Pharmacol. 7:689–693.
Hondeghem, L. M., and Katzung, B. G., 1977, Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels, Biochim. Biophys. Acta 472:373–398.
Hughes, S. M., 1983, Are guanine nucleotide binding proteins a distinct class of regulatory proteins? FEBS Lett. 164:1–8.
Janis, R. A., and Scriabine, A., 1983, Sites of action of Ca2+ channel inhibitors. Biochem. Pharmacol 32:3499–3507.
Janis, R. A., and Triggle, D. J., 1983, New developments in Ca2+ channel antagonists, J. Med. Chem. 26:775–785.
Janis, R. A., Rampe, D., Sarmiento, J. G., and Triggle, D. J., 1984a, Specific binding of a calcium channel activator, [3H]Bay K 8644 to membranes from cardiac muscle and brain, Biochem. Biophys. Res. Commun. 121:317–323.
Janis, R. A., Sarmiento, J. G., Maurer, S. C., Bolger, G. T., and Triggle, D. J., 1984b, Characteristics of the binding of [3H]Nitrendipine to rabbit ventricular membranes: Modification by other Ca2+ channel antagonists and by the Ca2+ channel agonist, Bay K 8644, J. Pharmacol Exp. Ther. 231:8–15.
Kazazoglou, T., Schmid, A., Renaud, J. R., and Lazdunski, M., 1983, Ontogenicappearance of Ca2+ channels characterized as binding sites for nitrendipine during development of nervous, skeletal and cardiac muscle systems in the rat, FEBS Lett. 164:75–79.
Krupp, M. N., Connolly, D. T., and Lane, M. D., 1982, Synthesis, turnover and downregulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts, J. Biol. Chem. 257:11489–11496.
Langs, D. A., and Triggle, D. J., 1985, Conformational features of calcium channel agonist and antagonist analogs of nifedipine, Mol. Pharmacol. 27:544–548.
Lee, K. S., and Tsien, R. W., 1983, Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialyzed heart cells. Nature 302:790–794.
Leff, S. E., Gariano, R., and Creese, L, 1984, Dopamine receptor turnover rates in rat striatum are age-dependent, Proc. Natl. Acad. Sci. U.S.A. 81:3910–3914.
Loev, B., Goodman, M. M., Snader, K. M., Tedeschi, R., and Macko, E., 1974, “Hantzsch-type” dihydropyridine hypotensive agents, J. Med. Chem. 17:956–965.
Luchowski, E., Yousif, F., Triggle, D. J., Maurer, S. C., Sarmiento, J. G., and Janis, R. A., 1984, Effects of metal cations and calmodulin antagonists on [3H]Nitrendipine binding in smooth and cardiac muscle, J. Pharmacol. Exp. Ther. 230:607–613.
Mauger, J. P., Sladeczek, F., and Bockaert, J., 1982, Characteristics and metabolism of ai-adrenergic receptors in a nonfusing muscle cell line, J. Biol. Chem. 257:875–879.
McDonald, T. F., Pelzer, D., and Trautwein, W., 1984, Cat ventricular muscle treated with D 600: Characteristics of calcium channel block and unblock, J. Physiol. (Lond.) 352:217–241.
Miller, R. J., and Freedman, S. B., 1984, Are dihydropyridine binding sites voltage-sensitive calcium channels? Life Sci. 34:1205–1221.
Molski, T. F. P., Naccache, P. H., Marsh, M. L., Kermode, T., Becker, E. L., and Sha’afi, R. I., 1984, Pertussis toxin inhibits the rise in the intracellular concentration of free calcium that is induced by chemotactic factors in rabbit neutrophils: Possible role of the “G proteins” in calcium mobilization, Bioehem. Biophys. Res. Commun. 124:664–650.
Opie, L. H., 1984, Calcium ions, drug action and the heart—with special reference to calcium antagonist drugs, Pharmacol. Ther. 25:271–295.
Pelzer, D., Trautwein, W., and McDonald, T. F., 1982, Calcium channel block and recovery from block in mammalian ventricular muscle treated with organic channel inhibitors, Pflüegers Arch. 394:97–105.
Rampe, D., Janis, R. A., and Triggle, D. J., 1984, Interaction of Bay K 8644, a 1,4-dihydropyridine Ca2+ channel activator: Dissociation of binding and functional effects in brain synaptosomes, J. Neurochem. 43:1688–1692.
Renaud, J. F., Romey, G., Lomget, A., and Lazdunski, M., 1981, Differentiation of the fast Na+ channel in embryonic heart cells: Interaction of the channel with neurotoxins, Proc. Natl. Acad. Sci. U.S.A. 78:5348–5352.
Renaud, J. F., Kazazoglou, T., Schmid, A., Romey, G., and Lazdunski, M., 1984, Differentiation of receptor sites for [3H]Nitrendipine in chick hearts and physiological relation to the slow Ca2+ channel and to excitation-contraction coupling, Eur. J. Bioehem. 139:673–681.
Rodenkirchen, R., Bayer, R., Steiner, R., Bossert, F., Meyer, H., and Moller, E., 1979, Structure-activity studies on nifedipine in isolated cardiac muscles, Naunyn Sehmiedebergs Arch. Pharmacol. 310:69–78.
Rosenberger, L. B., and Triggle, D. J., 1978, Calcium, calcium translocation and specific calcium antagonists, in: Calcium and Drug Action (G. B. Weiss, ed.), Plenum Press, New York, pp. 3–31.
Sanguinetti, M. C., and Kass, R. S., 1984a, Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists, Cire. Res. 55:336–348.
Sanguinetti, M. C., and Kass, R., 1984b, Regulation of cardiac calcium current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent, J. Mol. Cell. Cardiol. 16:667–670.
Schmid, A., Renaud, J. F., Fosset, M., Meaux, J. P., and Lazdunski, M., 1984, The ni-trendipine-sensitive Ca2+ channel in chick muscle cells and its appearance during myogenesis in vitro and in vivo, J. Biol. Chem. 259:11366–11372.
Schramm, M., Thomas G., Towart, F., and Franckowiak, G., 1983, Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303:535–537.
Schwartz, A., and Triggle, D. J., 1984, Cellular action of calcium channel blocking drugs, Annu. Rev. Med. 35:325–339.
Scidel, W., Meyer, H., Bom, L., Kazda, S., and Dompert, W., 1984, Rigid calcium antagonists of the nifedipine type: Geometrical requirements for the dihydropyridine receptor. Abstr. Am. Chem. Soc. 187.
Standen, N. B., and Stanfield, P. R., 1982, A binding-site model for calcium channel inactivation that depends on calcium entry, Proc. R. Soc. Lond. [Biol.] 217:101–110.
Su, C. M., Swamy, V. C., and Triggle, D. J., 1984, Calcium channel activation in vascular smooth muscle by Bay K 8644, Can. J. Physiol. Pharmacol. 62:1401–1410.
Triggle, A. M., Shefter, E., and Triggle, D. J., 1980, Crystal structures of calcium channel antagonists: 2,6-DimethyI-3,5-dicarbomethoxy-4[2-nitro,-3-cyano-, 4-(dimethylamino)- and 2,3,4,5,6,-pentafluorophenyl]-l,4-dihydropyridine, J. Med. Chem. 23:1442–1445.
Triggle, D. J., 1984, Ca2+ channels revisited: Problems and promises,Trends Pharmacol. Sci. 5:4–5.
Triggle, D. J., and Janis, R. A., 1984, Calcium channel antagonists: New perspectives from the radioligand binding assay, in: Modern Methods in Pharmacology, Vol. II (N. Back and S. Spector, eds.), Alan R. Liss, New York, pp. 1–28.
Triggle, D. J., and Janis, R. A., 1985, The 1,4-dihydropyridine receptor: A regulatory component of the Ca2+ channel, J. Cardiovasc. Pharmacol. 6:894–955.
Triggle, D. J., and Swamy, V. C., 1983, Calcium antagonists: Some chemical-pharmacological aspects,Circ. Res. 52(Suppl. I): 17–28.
Weiland, G. A., Minneman, K. P., and Molinoff, P. B., 1980, Thermodynamics of agonist and antagonist interactions with mammalian ß-adrenergic receptors, Mol. Pharmacol. 18:341–347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Triggle, D.J., Skattebol, A., Rampe, D., Joslyn, A., Gengo, P. (1986). Chemical Pharmacology of Ca2+ Channel Ligands. In: Poste, G., Crooke, S.T. (eds) New Insights into Cell and Membrane Transport Processes. New Horizons in Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5062-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5062-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5064-4
Online ISBN: 978-1-4684-5062-0
eBook Packages: Springer Book Archive